Perbak Capital Partners »

Alnylam Pharmaceuticals shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $399k 1.2k 330.87

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr State Street Ind (XLI)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Con (XLP)
Vaneck Etf Trust Oil Services Etf (OIH)
Spdr Series Trust State Street Spd (KIE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Select Sector Spdr Tr State Street Mat (XLB)
Select Sector Spdr Tr State Street Hea (XLV)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
Ishares Tr Ishares Semicdtr (SOXX)
Draftkings Com Cl A (DKNG)
Spdr Series Trust State Street Spd (XHB)
Northrop Grumman Corporation (NOC)

View all positions for Perbak Capital Partners

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Wellington Management Company
Dodge & Cox
American Century Companies
D. E. Shaw & Co
ClearBridge Advisors

View all funds holding Alnylam Pharmaceuticals